Description
EMPAFLO M 12.5/1000mg, supplied in a pack of 30 tablets, is a robust combination medication for adults with type 2 diabetes. Each tablet uniquely combines Empagliflozin 12.5mg and Metformin Hydrochloride 1000mg. Empagliflozin, an SGLT2 inhibitor, helps the kidneys excrete excess glucose, while Metformin, a biguanide, reduces glucose production and improves insulin sensitivity. This synergistic action effectively lowers blood sugar levels. Beyond glycemic control, EMPAFLO M 12.5/1000mg also offers significant benefits by reducing the risk of cardiovascular death, hospitalization for heart failure, and progression of chronic kidney disease in eligible patients. Used as an adjunct to diet and exercise, it provides comprehensive support for long-term diabetes management.
